Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 269

1.

Immunophenotypic features of dedifferentiated endometrial carcinoma Insights from BRG1/INI1-deficient tumors.

Hoang LN, Lee YS, Karnezis AN, Tessier-Cloutier B, Almandani N, Coatham M, Gilks CB, Soslow RA, Stewart CJ, Köbel M, Lee CH.

Histopathology. 2016 Apr 22. doi: 10.1111/his.12989. [Epub ahead of print]

PMID:
27101785
2.

Loss of SMARCA4 (BRG1) Protein Expression by Immunohistochemistry in Small Cell Carcinoma of the Ovary, Hypercalcemic Type Distinguishes these Tumors from their Mimics.

Clarke BA, Witkowski L, Ton Nu TN, Shaw PA, Gilks CB, Huntsman D, Karnezis T, Sebire N, Lamovec J, Roth LM, Stewart CJ, Hasselblatt M, Foulkes WD, McCluggage WG.

Histopathology. 2016 Apr 21. doi: 10.1111/his.12988. [Epub ahead of print]

PMID:
27100627
3.

Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study.

Köbel M, Atenafu EG, Rambau PF, Ferguson SE, Nelson GS, Ho TC, Panzarella T, McAlpine JN, Gilks CB, Clarke BA, Bernardini MQ.

Gynecol Oncol. 2016 Apr 15. pii: S0090-8258(16)30109-3. doi: 10.1016/j.ygyno.2016.04.008. [Epub ahead of print]

PMID:
27072807
4.

BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer.

Stamp JP, Gilks CB, Wesseling M, Eshragh S, Ceballos K, Anglesio MS, Kwon JS, Tone A, Huntsman DG, Carey MS.

Int J Gynecol Cancer. 2016 Apr 5. [Epub ahead of print]

PMID:
27051059
5.

Adopting a Uniform Approach to Site Assignment in Tubo-Ovarian High-Grade Serous Carcinoma: The Time has Come.

Singh N, Gilks CB, Hirshowitz L, Wilkinson N, McCluggage WG.

Int J Gynecol Pathol. 2016 May;35(3):230-7. doi: 10.1097/PGP.0000000000000270.

PMID:
26977579
6.

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.

Köbel M, Rahimi K, Rambau PF, Naugler C, Le Page C, Meunier L, de Ladurantaye M, Lee S, Leung S, Goode EL, Ramus SJ, Carlson JW, Li X, Ewanowich CA, Kelemen LE, Vanderhyden B, Provencher D, Huntsman D, Lee CH, Gilks CB, Mes Masson AM.

Int J Gynecol Pathol. 2016 Mar 11. [Epub ahead of print]

PMID:
26974996
7.

Ovarian Carcinoma Histotypes: Their Emergence as Important Prognostic and Predictive Markers.

Gilks CB, Kommoss F.

Oncology (Williston Park). 2016 Feb;30(2):178-9. No abstract available.

8.

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.

Harrington BS, He Y, Davies CM, Wallace SJ, Adams MN, Beaven EA, Roche DK, Kennedy C, Chetty NP, Crandon AJ, Flatley C, Oliveira NB, Shannon CM, deFazio A, Tinker AV, Gilks CB, Gabrielli B, Brennan DJ, Coward JI, Armes JE, Perrin LC, Hooper JD.

Br J Cancer. 2016 Feb 16;114(4):417-26. doi: 10.1038/bjc.2015.471. Epub 2016 Feb 4.

PMID:
26882065
9.

Rare cancers: a sea of opportunity.

Boyd N, Dancey JE, Gilks CB, Huntsman DG.

Lancet Oncol. 2016 Feb;17(2):e52-61. doi: 10.1016/S1470-2045(15)00386-1. Review.

PMID:
26868354
10.

Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.

Sheffield BS, Kos Z, Asleh-Aburaya K, Wang XQ, Leung S, Gao D, Won J, Chow C, Rachamadugu R, Stijleman I, Wolber R, Gilks CB, Myles N, Thomson T, Hayes MM, Bernard PS, Nielsen TO, Chia SK.

Breast Cancer Res Treat. 2016 Feb;155(3):483-90. doi: 10.1007/s10549-016-3689-z. Epub 2016 Feb 4.

PMID:
26846986
11.

Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality.

Anglesio MS, Wang YK, Maassen M, Horlings HM, Bashashati A, Senz J, Mackenzie R, Grewal DS, Li-Chang H, Karnezis AN, Sheffield BS, McConechy MK, Kommoss F, Taran FA, Staebler A, Shah SP, Wallwiener D, Brucker S, Gilks CB, Kommoss S, Huntsman DG.

J Natl Cancer Inst. 2016 Feb 1;108(6). pii: djv428. doi: 10.1093/jnci/djv428. Print 2016 Jun.

PMID:
26832771
12.

Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide.

Singh N, Gilks CB, Hirschowitz L, Kehoe S, McNeish IA, Miller D, Naik R, Wilkinson N, McCluggage WG.

Gynecol Oncol. 2016 May;141(2):195-8. doi: 10.1016/j.ygyno.2015.10.022. Epub 2016 Jan 28. No abstract available.

PMID:
26827965
13.

Outcomes of Incidental Fallopian Tube High-Grade Serous Carcinoma and Serous Tubal Intraepithelial Carcinoma in Women at Low Risk of Hereditary Breast and Ovarian Cancer.

Chay WY, McCluggage WG, Lee CH, Köbel M, Irving J, Millar J, Gilks CB, Tinker AV.

Int J Gynecol Cancer. 2016 Mar;26(3):431-6. doi: 10.1097/IGC.0000000000000639.

PMID:
26807643
14.

The cell surface mucin podocalyxin regulates collective breast tumor budding.

Graves ML, Cipollone JA, Austin P, Bell EM, Nielsen JS, Gilks CB, McNagny KM, Roskelley CD.

Breast Cancer Res. 2016 Jan 22;18(1):11. doi: 10.1186/s13058-015-0670-4.

15.

Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis.

McConechy MK, Talhouk A, Leung S, Chiu D, Yang W, Senz J, Reha-Krantz LJ, Lee CH, Huntsman DG, Gilks CB, McAlpine JN.

Clin Cancer Res. 2016 Jan 13. [Epub ahead of print]

PMID:
26763250
16.

p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.

Cheng AS, Karnezis AN, Jordan S, Singh N, McAlpine JN, Gilks CB.

Int J Gynecol Pathol. 2015 Dec 1. [Epub ahead of print]

PMID:
26630231
17.

Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma: Canadian Immunohistochemistry Quality Control (CIQC) Experience.

Lee S, Piskorz AM, Le Page C, Mes Masson AM, Provencher D, Huntsman D, Chen W, Swanson PE, Gilks CB, Köbel M.

Int J Gynecol Pathol. 2016 May;35(3):209-21. doi: 10.1097/PGP.0000000000000251.

PMID:
26598982
18.

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes.

Hunter SM, Anglesio MS, Ryland GL, Sharma R, Chiew YE, Rowley SM, Doyle MA, Li J, Gilks CB, Moss P, Allan PE, Stephens AN, Huntsman DG, deFazio A, Bowtell DD; Australian Ovarian Cancer Study Group, Gorringe KL, Campbell IG.

Oncotarget. 2015 Nov 10;6(35):37663-77. doi: 10.18632/oncotarget.5438.

19.

Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.

Köbel M, Meng B, Hoang LN, Almadani N, Li X, Soslow RA, Gilks CB, Lee CH.

Am J Surg Pathol. 2016 Feb;40(2):166-80. doi: 10.1097/PAS.0000000000000536.

PMID:
26492180
20.

Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy.

Bakhsh S, Kinloch M, Hoang LN, Soslow RA, Köbel M, Lee CH, McAlpine JN, McConechy MK, Gilks CB.

Histopathology. 2016 May;68(6):916-24. doi: 10.1111/his.12878. Epub 2015 Dec 17.

PMID:
26416160
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk